• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
J0401627 ICL670 deferasirox Active ingredient Chemical Drugs(1.1) Import Drug Application 2004-09-05 Beijing Novartis Pharma Co Ltd Certificate Issued 2005-03-16 view
JXHL1500277 ICL670 deferasirox Active ingredient Chemical Drugs Import Drug Application 2015-11-13 Novartis Pharma Schweiz AG Certificate Issued 2016-07-25 view
JXHL1500276 ICL670 deferasirox Active ingredient Chemical Drugs Import Drug Application 2015-11-13 Novartis Pharma Schweiz AG Certificate Issued 2016-07-25 view
J0401626 ICL670 deferasirox Active ingredient Chemical Drugs(1.1) Import Drug Application 2004-09-05 Beijing Novartis Pharma Co Ltd Certificate Issued 2005-03-16 view
J0401628 ICL670 deferasirox Active ingredient Chemical Drugs(1.1) Import Drug Application 2004-09-05 Beijing Novartis Pharma Co Ltd Certificate Issued 2005-03-16 view
JXHL1500278 ICL670 deferasirox Active ingredient Chemical Drugs Import Drug Application 2015-11-13 Novartis Pharma Schweiz AG Certificate Issued 2016-07-25 view
CXHL1500673 地拉罗司 deferasirox Active ingredient Chemical Drugs(3.1) New Drug Application 2015-08-12 湖北华世通生物医药科技有限公司 Waterstone Pharmaceuticals (HuBei) Co Ltd Certificate Issued 2016-08-01 view
CXHS1300059 地拉罗司 deferasirox Active ingredient Chemical Drugs(3.1) New Drug Application 2013-05-02 连云港宏创药业有限公司 Lianyungang Hongchuang Pharmaceutical Co Ltd Certificate Issued 2015-12-30 view
CXHL1401847 地拉罗司 deferasirox Active ingredient Chemical Drugs(3.1) New Drug Application 2015-02-13 江苏奥赛康药业股份有限公司 Jiangsu Aosaikang Pharmaceutical Co Ltd Certificate Issued 2016-02-19 view
JYHB2000891 地拉罗司分散片 deferasirox Tablet Chemical Drugs Supplementary Application 2020-06-19 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Filed 2020-06-22 view
JXHL1100208 地拉罗司分散片 deferasirox Tablet Chemical Drugs Import Drug Application 2011-07-12 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Certificate Issued 2012-03-29 view
JXHL0600131 地拉罗司分散片 deferasirox Tablet Chemical Drugs(3.1) Import Drug Application 2006-05-10 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2007-10-19 view
JYHB1700601 地拉罗司分散片 deferasirox Tablet Chemical Drugs Supplementary Application 2017-04-28 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2018-02-27 view
JYHB2200160 地拉罗司分散片 deferasirox Tablet Chemical Drugs Supplementary Application 2022-03-29 view
CYHS1300315 地拉罗司分散片 deferasirox Tablet Chemical Drugs(6) Generic Drug 2013-07-03 江苏豪森药业股份有限公司 Jiangsu Hansoh Pharmaceutical Group Co Ltd Certificate Issued 2015-12-30 view
JYHB1000301 地拉罗司分散片 deferasirox Tablet Chemical Drugs Supplementary Application 2010-04-28 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Certificate Issued 2010-06-29 view
JXHL1800016 地拉罗司分散片 deferasirox Tablet Chemical Drugs(5.2) Import Drug Application 2018-02-02 瑞迪博士(无锡)制药有限公司 Dr Reddys (WUXI) Pharmaceutical Co Ltd Certificate Issued 2018-07-06 view
JYHB1600137 地拉罗司分散片 deferasirox Tablet Chemical Drugs Supplementary Application 2016-02-16 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2016-11-24 view
JXHL1400211 地拉罗司分散片 deferasirox Tablet Chemical Drugs Import Drug Application 2014-06-20 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Certificate Issued 2015-09-01 view
JYHZ1900280 地拉罗司分散片 deferasirox Tablet Chemical Drugs License Renew 2019-11-01 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2020-01-10 view